FMS icon

Fresenius Medical Care

25.92 USD
-0.23
0.88%
Updated Jul 30, 1:19 PM EDT
1 day
-0.88%
5 days
-5.12%
1 month
-9.28%
3 months
2.13%
6 months
3.93%
Year to date
17.02%
1 year
32.04%
5 years
-41.21%
10 years
-36.84%
 

About: Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Employees: 112,035

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

137% more call options, than puts

Call options by funds: $3.06M | Put options by funds: $1.29M

88% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 16

23% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 52

13% more capital invested

Capital invested by funds: $770M [Q4 2024] → $873M (+$103M) [Q1 2025]

5% more funds holding

Funds holding: 188 [Q4 2024] → 198 (+10) [Q1 2025]

0.35% more ownership

Funds ownership: 11.59% [Q4 2024] → 11.94% (+0.35%) [Q1 2025]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 0 (-1) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$30
16%
upside
Avg. target
$30
16%
upside
High target
$30
16%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Truist Securities
David Macdonald
16%upside
$30
Hold
Maintained
12 May 2025

Financial journalist opinion

Based on 11 articles about FMS published over the past 30 days

Neutral
Zacks Investment Research
2 hours ago
Here's Why Fresenius (FMS) Looks Ripe for Bottom Fishing
Fresenius (FMS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Here's Why Fresenius (FMS) Looks Ripe for Bottom Fishing
Positive
Zacks Investment Research
1 day ago
Here's Why Fresenius (FMS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Fresenius (FMS) is a Strong Value Stock
Neutral
Zacks Investment Research
1 day ago
Is the Options Market Predicting a Spike in Fresenius Medical Stock?
Investors need to pay close attention to FMS stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Fresenius Medical Stock?
Positive
Seeking Alpha
1 week ago
Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)
Fresenius Medical Care (FMS) is rated a buy, with shares up 32.95% YoY and strong Q1 2025 results, showing 60% (YoY) net income growth. My valuation using a forward P/S ratio suggests FMS is undervalued by over 130%, with a projected share price of $62.06 by 2026. Compared to peers, FMS offers the highest potential upside and a superior 3.07% dividend yield, making it an attractive value play.
Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)
Neutral
Zacks Investment Research
1 week ago
FMS or SONVY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Fresenius (FMS) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?
FMS or SONVY: Which Is the Better Value Stock Right Now?
Neutral
GlobeNewsWire
1 week ago
$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical
Explore the latest report on the global outpatient clinics market, analyzing trends, revenue, and forecasts from 2023 to 2029. This comprehensive study covers services, specialty, regional insights, and ESG impacts, featuring profiles of key players like Johns Hopkins and Mayo Clinic. Discover market dynamics and competitive landscape strategies. Explore the latest report on the global outpatient clinics market, analyzing trends, revenue, and forecasts from 2023 to 2029. This comprehensive study covers services, specialty, regional insights, and ESG impacts, featuring profiles of key players like Johns Hopkins and Mayo Clinic. Discover market dynamics and competitive landscape strategies.
$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical
Positive
Zacks Investment Research
2 weeks ago
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Negative
Zacks Investment Research
2 weeks ago
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Positive
Zacks Investment Research
3 weeks ago
4 High Earnings Yield Value Stocks You Should be Owning
Unlock your portfolio value by investing in stocks like FMS, EGO, HOPE and HRTG.
4 High Earnings Yield Value Stocks You Should be Owning
Positive
Zacks Investment Research
3 weeks ago
FMS vs. RXST: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those looking for undervalued stocks?
FMS vs. RXST: Which Stock Is the Better Value Option?
Charts implemented using Lightweight Charts™